Quantcast

Industry news that matters to you.  Learn more

Archives for April 2018

Quanterix Marks Leadership in Accelerating Neurology Research with 100-Publication Milestone

Quanterix Corporation, a company digitizing biomarker analysis with the goal of advancing the science of precision health, recently announced it has surpassed an important milestone that its technology has been highlighted in more than 100 third-party, peer-reviewed publications in neurology. Driven by increased demand for the company’s Simoa technology, which continues to prove itself as the industry standard for ultra-sensitive biomarker detection, this brings the total number of publications for the company to over 215 across neurology, oncology, cardiology, inflammation and infectious disease.